Previous Close | 2.0500 |
Open | 2.0700 |
Bid | 2.0500 x 0 |
Ask | 2.0700 x 0 |
Day's Range | 2.0500 - 2.0800 |
52 Week Range | 0.8100 - 2.2800 |
Volume | |
Avg. Volume | 18,347 |
Market Cap | 32.18M |
Beta (5Y Monthly) | 0.90 |
PE Ratio (TTM) | 11.39 |
EPS (TTM) | 0.1800 |
Earnings Date | Aug 21, 2024 - Aug 26, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Most readers would already be aware that BioRem's (CVE:BRM) stock increased significantly by 39% over the past three...
Biorem Inc. (TSXV:BRM)("Biorem", or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors of the Company to purchase up to an aggregate of 50,000 common shares in the capital stock of the Company. The options are exercisable at a price of $1.96 per share for a period of ten years from the date of grant.
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2024. BIOREM's complete 2024 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).